Evidence map›Paper›PMID 41707540›Full record

Observational studyBurns : journal of the International Society for Burn Injuries2026

Analysis of treatment pathways and long-term prevalence of pruritus after burn - An observational study with real-world data.

Julia Kleinhapl, Lucineia Gainski Danielski, John Nabei Ekale, Ragheb Khalidi, Ryan McAuley, Rudy Ji, Karl Mueller, Julia W Tripple, Jaclyn Dempsey, Helen Tran and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Burns : journal of the International Society for Burn Injuries, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Julia KleinhaplDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States; Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.
Lucineia Gainski DanielskiDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States.
John Nabei EkaleHuman Pathophysiology and Translational Medicine Graduate Program, University of Texas Medical Branch, Galveston, TX, United States.
Ragheb KhalidiThe University of Texas Medical Branch Summer Institute in Biostatistics and Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX, United States.
Ryan McAuleyDepartment of Neurobiology, University of Texas Medical Branch, Galveston, TX, United States.
Rudy JiDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States.
Karl MuellerDivision of Allergy & Immunology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.
Julia W TrippleDivision of Allergy & Immunology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.
Jaclyn DempseyDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States.
Helen TranThe University of Texas Medical Branch Summer Institute in Biostatistics and Data Science, School of Public and Population Health, University of Texas Medical Branch, Galveston, TX, United States.
Ludwik BranskiDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States; Shriners Children's Texas, Galveston, TX, United States.
George GolovkoDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston.
Steven E WolfDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States.
Celeste C FinnertyDepartment of Surgery, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: ccfinner@utmb.edu.

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
POSTDOCTORAL TRAINING IN TRAUMA &BURNST32GM008256 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Celeste Campbell Finnerty, Oscar E. Suman-Vejas · 1990 to 2026
$4.0M
The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS)R25HL161715 · NHLBI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HEIDI SPRATT · 2022 to 2026
$1.3M
NCATS NIH HHS UL1 TR001439NHLBI NIH HHS R25 HL161715NIGMS NIH HHS T32 GM008256
6 · The paper itself

Abstract

introductionBurns heal with long-lasting scars and complications, such as persistent pruritus. To date, there is no consensus on optimal treatment. This study aims to identify prevalence and treatment patterns of burn-related pruritus using a large dataset.

methodsA retrospective cohort study was conducted using the real-world database TriNetX. Burn patients were identified and stratified into three cohorts by extent of total body surface area (TBSA) burned: Cohort 1 (<20 %; mild), Cohort 2 (20-39 %; moderate), and Cohort 3 (≥40 %; severe). Prevalence of pruritus, eosinophilia status, and treatment patterns were assessed. Age group and temporal effects were tested using Chi-square.

resultsWe identified 257,360 burn patients with a mean age of 37 ± 23 years. Pruritus prevalence ranged from 3.29 % to 7.95 % in paediatric patients and from 1.50 % to 9.75 % in adult patients. Peak prevalence occurred in those with 20-39 % TBSA burned, aged 41-60 years, and within 3 years after burn. Severe eosinophilia peaked in 41-60-year-olds with burns > 40 % of TBSA. The most commonly prescribed drug classes across all cohorts were H1-antihistamines, 5-HT3 receptor antagonists, and neuropathic pain drugs.

conclusionOur real-world database analysis indicates that the prevalence of post-burn pruritus varies by age and burn size, showing a tendency to decrease with age but increase over time. The highest prevalence was observed in patients with moderate-sized burns (20-39 % TBSA burned). Treatment patterns remain inconsistent, underscoring the need for standardized and evidence-based strategies.

Indexed as

BurnsEosinophiliaPruritusAdolescentAdultAnalgesicsBody Surface AreaChildChild, PreschoolFemaleHistamine H1 AntagonistsHumansInfantMaleMiddle AgedPrevalenceAnalgesicsHistamine H1 AntagonistsBurn complicationBurn scarCicatrixEosinophiliaItchPruritusTrinetx

Identifiers

PMID41707540
PMCPMC13602405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.